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Abstract
Background: The German cDNA Consortium has been cloning full length cDNAs and continued with their
exploitation in protein localization experiments and cellular assays. However, the efficient use of large cDNA
resources requires the development of strategies that are capable of a speedy selection of truly useful cDNAs
from biological and experimental noise. To this end we have developed a new high-throughput analysis tool,
CAFTAN, which simplifies these efforts and thus fills the gap between large-scale cDNA collections and their
systematic annotation and application in functional genomics.
Results: CAFTAN is built around the mapping of cDNAs to the genome assembly, and the subsequent analysis
of their genomic context. It uses sequence features like the presence and type of PolyA signals, inner and flanking
repeats, the GC-content, splice site types, etc. All these features are evaluated in individual tests and classify
cDNAs according to their sequence quality and likelihood to have been generated from fully processed mRNAs.
Additionally, CAFTAN compares the coordinates of mapped cDNAs with the genomic coordinates of reference
sets from public available resources (e.g., VEGA, ENSEMBL). This provides detailed information about overlapping
exons and the structural classification of cDNAs with respect to the reference set of splice variants.
The evaluation of CAFTAN showed that is able to correctly classify more than 85% of 5950 selected "known
protein-coding" VEGA cDNAs as high quality multi- or single-exon. It identified as good 80.6 % of the single exon
cDNAs and 85 % of the multiple exon cDNAs.
The program is written in Perl and in a modular way, allowing the adoption of this strategy to other tasks like
EST-annotation, or to extend it by adding new classification rules and new organism databases as they become
available. We think that it is a very useful program for the annotation and research of unfinished genomes.
Conclusion: CAFTAN is a high-throughput sequence analysis tool, which performs a fast and reliable quality
prediction of cDNAs. Several thousands of cDNAs can be analyzed in a short time, giving the curator/scientist a
first quick overview about the quality and the already existing annotation of a set of cDNAs. It supports the
rejection of low quality cDNAs and helps in the selection of likely novel splice variants, and/or completely novel
transcripts for new experiments.
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Background
The availability of a growing number of draft or com-
pleted genomes has shifted the most pressing challenges
towards the understanding of the molecular and cellular
biology of genes and other encoded elements. This under-
standing is facilitated by the interpretation of genomes
not only in terms of their structure but also of their func-
tion and diversity. To this end cDNAs from several human
large-scale sequencing projects [1-3] have proven their
usefulness in the identification and annotation of gene
structures and splice forms [4]. These projects have estab-
lished and improved methodologies for the production of
cDNA libraries, enriched in full length and rare transcripts
[5-7], which was mandatory for the discovery of new tar-
gets for functional genomics. In addition to the utilization
of cDNAs in genome and gene annotation, this physical
resource provides the basis for the molecular and cellular
functional analysis of the encoded proteins [8], and of
functional RNAs.
The German cDNA Consortium has pioneered the large-
scale sequencing of full-length cDNAs [1] and their sys-
tematic exploitation in protein localization experiments
[9]. Initial sequence annotations have been integrated
with experimental data and bioinformatics analysis
[10,8]. One example is the LIFEdb database [11], which is
used as a front-end tool for the dissemination of informa-
tion and for manual and automated annotation. Several
large-scale applications of cell-based assays have since
been implemented to define candidates for further studies
and to identify their potential impact in disease [12], [13].
However, the initial annotation of cDNAs and deduced
ESTs has to face a considerable amount of biological and
experimental noise [14-16], though some of the observed
phenomena (e.g. retained introns) may be biologically
significant [17,18]. Accurate cDNA annotation has tradi-
tionally been achieved via manual curation, using the
experience of expert individuals to annotate sequences
manually. Although manual curation can attain high
degrees of accuracy [4,19], it cannot keep pace with the
continuously growing number of entries in sequence and
other databases [20]. A straightforward decision process
in the selection of cDNAs for experimental analysis of
encoded proteins is therefore a key factor for the creation
of relevant datasets within the functional genomics analy-
sis of genes and proteins.
We have developed a new high-throughput cDNA analysis
tool, CAFTAN, which filters sequences based on their
potential to be derived from full-length and fully proc-
essed transcripts and spliced forms. It identifies and filters
those cDNAs containing incompletely processed or trun-
cated transcripts, which are consequences of erroneous
mRNA processing [16] or of errors in the cloning process.
Thus this filtering of targets saves time in the selection of
cDNA templates for the subsequent sub-cloning of open
reading frames and the functional characterization of
encoded proteins.
The main strategy of CAFTAN is based on the mapping of
cDNAs to the genome assembly, and the analysis of their
genomic context. The presence and type of polyA signals,
internal and flanking repeats, the GC-content, and splice
site types are evaluated in different tests and aid in the
classification of cDNAs into several groups according to
their sequence quality. CAFTAN compares the coordinates
of cDNAs in the respective genomic locus with the coordi-
nates of a reference set of cDNA-sequences from publicly
available resources (e.g., VEGA [21], ENSEMBL [22]). It
thus generates detailed information about overlapping
exons and a structural classification of any cDNAs with
respect to the reference set of transcripts and splice vari-
ants.
We applied this tool to a set of 5950 human cDNAs anno-
tated as "known protein-coding" cDNAs in VEGA (Verte-
brate Genome Annotation database) [see Additional files
4 and 5] [21]. VEGA is a central repository for manual
annotation of vertebrate finished genome sequences. It
thus generates detailed information about overlapping
exons and a structural classification of any cDNAs with
respect to the reference set of transcripts and splice vari-
ants. The results showed that CAFTAN was able to classify
correctly more than 85% of the analyzed cDNAs. Its good
performance makes it suitable for providing the curator/
scientist a first and fast overview about the quality and the
already existing annotation of a set of cDNA. CAFTAN
does not substitute the hand curation process and further
detailed ORF analysis; however it supports the selection or
rejection of targets, thus speeding up the discovery process
in the lab.
Implemetation
The implementation of the CAFTAN method can be sum-
marized in the following stages: 1) input or raw data, 2)
Extraction of simple and composite features from raw data, 3)
Rules definitions, 4) Prediction and Evaluation, 5) Program
specifications
Input (Raw Data)
CAFTAN takes as input a multiple FastA file of the cDNAs
to be analyzed and a BLAT output from the FastA
sequence file in pSL format with header [23,24].
Feature extraction
Simple and composite features were extracted from a
training set of 3500 manually curated sequences from the
German Human cDNA Project -DKFZ collection (supple-
mentary information). Afterwards, the distribution of
these features was studied depending on their tag- in theBMC Bioinformatics 2006, 7:473 http://www.biomedcentral.com/1471-2105/7/473
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curated DKFZ set- (e.g. "good", "bad", "with deletions",
"primed"), see section 2.2.
Simple Feature Extraction
Exon Mapping Refinement
The first step is to know where and how good the cDNAs
are localized in the genome. For that purpose we use
BLAT, which maps most cDNAs to a single position/locus
in the human genome. However, recent gene duplication
events, repeat elements in cDNAs, or misassemble of
genome sequence contigs give rise to the mapping of
cDNAs at multiple loci, making a post processing of the
BLAT output (given by the user) necessary. Only the hit
with the lowest number of mismatches is selected. The
mapping positions of the selected hit are kept for use of
this cDNA in further analyses.
Afterwards, the distances between consecutive blocks-
matches of the cDNA to the genome in the BLAT output-
are analyzed; a block can be interpreted as an exon. The
blocks are joined when the distance is less than 10 bp in
the genome sequence. The final number of blocks and
their exact genomic positions are recalculated and stored.
This process is repeated for every cDNA.
Additionally information on the number of mismatches,
successfully mapped length, number of Ns, gaps etc. are
stored for the later generation of composite features and
rule definitions. (Figure 1, Table 1).
cDNA polyA signal and tail analysis
PolyA sites in mRNAs are defined by a hexameric polyade-
nylation signal, AAUAAA, or a one-base variant thereof
[25]. This signal is usually located ~15 bases upstream of
the cleavage site and, sometimes, there is also a GU
(Guanosyl Uridine)-rich element located 20–40 bases
downstream of the site [26]. The polyA polymerase then
adds a polyA tail to mRNAs during pre-mRNA matura-
tion.
We have developed the program "Polyasignal", using
EMBOSS libraries [see Additional files 2 and 3] [27], to
identify within cDNA sequences potential polyA signals in
the context of a polyA tail. The program retrieves the posi-
tion and type of every possible hit. It also allows searching
for sequences having only polyA signals or polyA tail.
The user can define almost all variables, such as maximum
distance allowed between the signal and the polyadenyla-
tion site (default 50nt), and patterns to match the polyA
signals and polyA tail. Parameters are by default opti-
mized for the human genome [25,28] but it can be easily
adapted for other organisms. All obtained information is
stored for the later creation of composite features and
rules extraction.
Feature extraction from assembly: splice sites, repeats, genomic 
polyA tail
Splice sites
Most exon/intron boundaries match consensus dinucle-
otides that are specific for splice donor and splice acceptor
sites at the 5' and 3' ends of exons, respectively [29]. All
putative splice donor and acceptor sites (Ss) are extracted
for every cDNA from the genome assembly (Table 1). U2
dependent introns have been historically classified in
those containing canonical splice sites with conserved GT
and AG dinucleotides and those containing GC-AG were
called non-canonical splice sites. U12-dependent introns
discovered later showed a preference for AT-AC dinucle-
otides in the splice donor/acceptor positions. We use this
classification to create the introns Ss types (Table 1:
canonical, non-canonical, u12 and unknown Ss), because
there is not an accepted standard nomenclature in the lit-
erature for the splice sites depending on the splicesome, or
on the combination of donor/acceptor dinucleotides used
by the intron.
Once the splice type of each intron in a cDNA has been
defined, the Ss type of the whole cDNA is then defined
(Table 1). The cDNA Splice Site Type is classified as canon-
ical only when all of its splice sites are canonical, for other
cases see Table 1.
CpG islands
The genomic sequence is further checked for CpG islands
up to 200 bp from the beginning of the cDNA. We use the
generally accepted definition of what constitutes a CpG
island [30].
Genomic polyA tail
Additionally, the presence of a stretch of multiple A's
(polyA tail) in the genome at the matching position of the
cDNA's end is checked. We look for a window of 20 bp in
the genome taking the last 5 bp of the last exon plus the
following 15 bp in the genome. If this 20 bp nucleotide
window has more than 80% A's content, then we assume
the presence of a genomic polyA.
Repeats
Repeat elements in the last exon and in the 5' and 3'end
of thequery cDNA are identified. The repeats in these
regions are searched as follow: those overlapping the last
block/exon of a cDNA, those overlapping the first 50 bp
in the 5'upstream region, and repeats overlapping the ter-
minal 50 bp from the 3'downstream region. All informa-
tion is stored for the later generation of composite
features, rules and quality tests evaluation (Figure 1)BMC Bioinformatics 2006, 7:473 http://www.biomedcentral.com/1471-2105/7/473
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Caftan pipeline, data and program flow Figure 1
Caftan pipeline, data and program flow.
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) Table 1: cDNA features flow, generation of new features and type of test performed by CAFTAN
Type Tests Results> CAFTAN input Queries Derived features
Mapping CDNA coverage True if more than the 20% of the sequence is mapped to the genome
3'utr mapping True if delta3 < 50 bp. delta3 is the difference between the length of the cDNA and the last 
position mapped in the 3' end of the cDNA without poly (A) tail
5' utr mapping True if the cDNA start mapping position in the genome is < 28 bp Filtered BLAT
Internal mapping True if deltaint < 50 bp. Delta int is the number of mismatches in the cDNA exons taking 
into account the cDNA length
Exons Delta5' region
Delta3' region
Mapping Total mapping Unmapped: when 3'utr mapping, 5'utr mapping, and Internal mapping are False Exons length Delta int
Mapped: when 3'utr mapping, 5'utr mapping, and Internal mapping are True
Partial mapped: only two or one of the mapping test are false
CDNA Structure Single exon cDNA
Multiple exon cDNA
True if exon number = 1
True if exon number > 1
BLAT Output Filtered BLAT
Exons
Repeats (R) calculated 
for: 5' upstream, 3' 
downstream, Last exon
Repeats number
Complex R
Repeat type
Number
True if any of the following repeats is present: SVA R, Alu R, L1 R, LTR R, or ScRNA
Returns a string, the type of repeat in the 3 prima region depending of how many repeats 
in this region were found and how much can they influence the right cloning of the cDNA: 
Complex repeats > Simple repeats > Low complexity repeats
Genome assembly query
Repeats overlapping with the 
given regions
Simple R
Alu R
L1 R
SVA R
LTR R
ScRNA R
Low complexity R
Splice Sites (Ss) Number of Ss
cDNA Ss type
Ss-score
Number
Returns a string with the type depending on the Ss types in the cDNA
Unknown: at least one Unknown splice sites
Antisense: at least one antisense Ss, no Unknown
U12: at least one U12 Ss, no antisense and no unknown Ss
Non_canonical: only non canonical and cannonical Ss
Canonical: All splice sites are cannonical
Percent. Returns the % of good splice sites in a multi exon cDNA. Good splice sites are 
canonical, non canonical and u12 splice sites
Genome assembly query Canonical Ss "GT-AG"
Non_canonical Ss "GC-AG"
U12 Ss "AT-AC"
Antisense Ss "CT-GC","GT-AT"
Unknown Ss (others)
Returns a string with the type depending on the Ss types in the cDNA
cDNA Ss type Number
Unknown: at least one Unknown splice sites
Canonical Ss "GT-AG"
Antisense: at least one antisense Ss, no Unknown Non_canonical Ss "GC-AG"
U12: at least one U12 Ss, no antisense and no unknown Ss Genome assembly query U12 Ss "AT-AC"
Non_canonical: only non canonical and cannonical Ss Antisense Ss "CT-GC"
"GT-AT"
Ss-score Canonical: All splice sites are cannonical
Percent. Returns the % of good splice sites in a multi exon cDNA. Good splice sites are 
canonical, non canonical and u12 splice sites
Unknown Ss (others)
PolyA signal and tail cDNA signal type
Poly A tail
Returns a string with the type depending on:
Canonical: There is at least a canonical signal in the cDNA
Non-canonical a: There is no canonical signal and there is a non-canonical a onel
Non-canonical b: There is none of the above signals but there is a non-canonical b one
Non-canonical c: There is none of the above signals but there is a non-canonical c one
True if there is a poly (A) tail in the cDNA
Polyasignal 
Output
Signals:
Canonical A [TA]TAAA
Non-canonical a [^A]ATAAA
Non-canonical b AATA[^A]A
Non-canonical c A[CG]TAAA
Tail length
Contamination Contamination Returns a string with the type of contaminations
PolyA C: if there is more than 80% As in a 20 bp window in the genome. 5 last bp from the 
last exon + 15 bp after.
RepeatC: Complex repeats contamination in the last exon or 3' end
Mixed contamination: both contaminations
No Contamination: no polyA C and no RepeatC
Polyasignal 
Output
Genome assembly query Genomic polyA tail
Presence of complex RepeatsBMC Bioinformatics 2006, 7:473 http://www.biomedcentral.com/1471-2105/7/473
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Coordinate based comparison of the cDNA set with VEGA 
and ENSEMBL annotations
CAFTAN compares the coordinates of mapped cDNAs
after filtering with the genomic coordinates of reference
sets from the publicly available resources of the Vertebrate
Genome Annotation (VEGA) database [21] and
ENSEMBL [22](Figure 1). VEGA is a central repository for
manual annotation of vertebrate finished genome
sequences while ENSEMBL produces and maintains auto-
matic annotation on many eukaryotic genomes.
Each analyzed cDNA is linked to the best matching gene
in VEGA and/or ENSEMBL (Figure 1). Since VEGA genes
are organized in transcripts, the best matching transcript
needs to be selected. For that purpose, the coordinates of
all existing VEGA and/or ENSEMBL transcript variants for
the best matching gene are extracted and compared with
the query cDNA including all exon and intron coordi-
nates. An "exon score" defined as the ratio between the
exons overlap and the sum of their lengths, is calculated
for all transcript exons and query cDNA exons. Once the
exons have been compared all to all a "transcript score"
given below is calculated for every VEGA and/or ENSEMBL
transcript found to overlap with the query cDNA.
Transcript score = ((2*total_transcript_exon score)/
(mrna_exon_nr + cdna_ex_nr));
Here the "total_transcript_exon" score is the sum of all tran-
script exon scores and "mrna_exon_nr" and "cdna_ex_nr"
are the number of exons in the transcript and in the query
cDNA, respectively. The score can have values between 0
and 1, where 1 indicates a perfect match in all exons from
the VEGA/ENSEMBL transcript to all the exons of the
query cDNA and the same number of exons. The tran-
script with the highest score is selected as the best overlap-
ping one to the query cDNA. All its relevant information
is stored.
Composite Features
The extracted features are combined to calculate further
relevant information for each cDNA sequences (Figure 1,
composite features in Table 1).
Mapping
First the mapping of a cDNA sequence to the genome is
analyzed in detail. The percentage of a cDNA sequence
that can be mapped to the genome gives an indication of
possible colligation events during cDNA cloning, poten-
tial errors in the genome assembly, or the existence of
trans-splicing. All information obtained from the raw
BLAT output and its filtering is used to calculate the qual-
ity of the mapping process by taking into account the
number of mismatched positions internally and in the 3'
and 5' ends (Table 1).
cDNA Structure
The tests related to the cDNA structure determine if the
query cDNA was the product of a single exon or a multi-
exon gene and is calculated using the filtered BLAT Exon
results.
Repeats
the number of repeats in the three regions described
before in section 2.1.3, is analysed and post-processed to
distinguish between simple repeats, low complexity
repeats (mono-, di-, and tri-nucleotide repeats), and com-
plex repeats (SVA, Alu, LINE, SINE, LTR, ScRNA, other
complex repeats). The repeat type composite feature in the
corresponding region depends on how many repeats were
found and how much they could influence the right clon-
ing of the cDNA: Complex repeats > Simple repeats > Low
complexity repeats.
Splice sites score
Once the splice type of each intron in a cDNA has been
defined, the Ss type of the whole cDNA is then defined
(Table 1). The Ss-score is calculated as the percentage of
"good" splice sites in a multi-exon cDNA. Splice sites are
rated "good" when they match canonical, non-canonical,
or u12 donor-acceptor pairs. A higher Ss-score correlates
with a better quality of the respective cDNA. In the train-
ing set, cDNAs sequences with internal deletion, when
compared to a reference sequence, presented always a var-
iable percentage of bad splice sites along the total number
of splice sites. Therefore, the presence and type of splice
sites was valued as a positive feature for the cDNA classifi-
cation within CAFTAN. Such deletions are commonly
artefacts that occur in the bacteria after cloning, where
sequences of cDNA inserts are deleted by recombination.
Since this recombination is independent of splicing, these
events mostly do not occur at canonical splice sites
polyA signal and tail
The number and type of signals are calculated for each
cDNA using PolyAsignal and the results are used to create
the feature signal type (Table 1). The signal type is selected
according to the hexamer distribution [25] found. The
polyA signal selection ranking is in the following order, in
cases where more than one signal is found in one cDNA:
canonical > non-canonical_a > non-canonical_b > non-
canonical_c. Definitions of the hexamer types are given in
Table 1.
Contaminations
A polyA contamination is true if there is a polyA stretch in
the genome at the 3' mapping position of the terminal
cDNA exon, this is classified as a genomic polyA. Then the
3' end of the last exon is checked for the presence of com-
plex and simple repeats within its last 50 bp or 20 bp
respectively. If repeats are found in these regions theBMC Bioinformatics 2006, 7:473 http://www.biomedcentral.com/1471-2105/7/473
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cDNA has "repeat contamination". If more than one
repeat is found, only one will be shown with the follow-
ing preference: First complex repeats in the following
order, Alu > L1 > SVA > LTR, then simple repeats and last
low complexity repeats.
"Mixed contamination" means both types, ie. genomic
polyA and repeat contamination. The type of any putative
contamination is classified and stored (Table 1).
3. Rule generation
The distribution of simple and composite features
extracted from the training set (3500 DKFZ manually
curated cDNAs) was studied depending on their tag- in
the curated DKFZ set- (e.g. "good", "bad", "with dele-
tions", "primed") using clustering methods. We found
distinct relationships among features that were able to
characterize different sets of observations in the training
set. These profiles -relationships among features- were dis-
cussed and some times modified according to the cura-
tor's expert knowledge. The decision rules obtained are
presented in Table 2, and use the terminology from Table
1.
1.) "Uncovered", i.e. those cDNAs that mapped with less
than 20 % of their length to the genome, which usually
means the presence of too many gaps in the genome 2.)
"Bad_se", i.e. bad single exon cDNAs; 3.) "Bad_me", i.e.
bad multiple exon cDNAs; 4.) "Questionable_se", and 5.)
"Questionable_me", are cDNAs with single or multiple
exons, respectively, that should be manually inspected by
the curator/scientist in order to take a decision about their
quality; 6.) "Good_se_cdna", i.e., high quality single exon
cDNAs; 7.) "Good_me_cdna", i.e., high quality multiple
exon cDNAs; 8) "Partial_mapped", are cDNAs with gaps
bigger than 20 bp either in the 3', 5' end or in the internal
region 9.) "Undefined", are any cDNAs that do not fit into
one of the previous categories because they failed to pass
the evaluation pipeline. Elements in the latter group will
be used for the further refinement of the evaluation and
classification system.
The quality assessment starts with the evaluation of the
quality of a cDNA mapping to the genome. The decision
process is similar for multiple and single exon cDNAs
(Table 2). However, for the former ones further informa-
tion is required i.e., the Splice Sites Type definition (Ss
type) and especially the Splice Sites Score. The Splice Sites
Score (Table 1) was defined as the percentage of canoni-
cal, non-canonical and u12 donor-acceptors pairs in the
cDNA across the total number of donor-acceptor pairs. A
cDNA is not allowed to contain antisense other unknown
Ss to be classified as "Good splice sites". In contrast, the
"Bad" Splice Sites Type is attached to a cDNA when there
is at least one unknown or antisense splice site among the
donor acceptor pairs of a cDNA.
A cDNA is rated to be of high quality when it is perfectly
mapped to the genome, has a polyA signal and a polyA
tail, and in the case of multiple exons the Ss score is higher
than 60 % and the Ss type is "Good splice sites" (Table 2).
The Ss score is required to be higher than 90 % for a
cDNA, to be classified as high quality, in the case that it
contains "Bad splice sites". This means that at least one of
the donor-aceptor pairs is unknown or antisense. cDNAs
lacking the polyA signal are considered to be "Bad". Any
multiple exon cDNAs having Ss scores lower 60% are clas-
sified as "Bad_me" (refer to section 2.2.4).
cDNAs with one type of contamination repeats, or
genomic polyA and/or lacking the polyA tail need to fulfill
other criteria in order not to be classified as "Bad" (Table
2). The presence of complex repeats in the last exon of the
cDNA is considered negatively in the quality selection
process. Alu sequences, like other SINEs, occur at higher
frequency within non-coding domains of single copy
genes (e.g. inter-genic regions, introns, 5' and 3' UTRs, etc)
and they can affect the processing of pre-mRNAs leading
to altered gene products [31]. In addition, the presence of
Alu sequences and other retro-transposable elements
(Mir, LINES, ect) in pre-mRNA can affect Polyadenylation
of transcripts and influence transcription as well [32,33].
These repeats can be present in total RNA pool used to
obtain cDNA library (e.g., when RNA polyA enrichment
fails). This situation makes possible the priming of other
mRNAs -especially partially spliced- during amplification
(DKFZ curated data). As result incomplete/problematic
cDNA sequences are produced. (Intronic) Alu repeats fre-
quently contain polyA sequences at the genomic level and
these often serve as oligo dT-priming sites in the cDNA
generation process. Such cDNAs are usually 3' truncated
and mostly terminate in intronic sequences. Since this
phenomenon is quite frequent we included the presence
of an Alu sequence at the 3' terminal end of a cDNA as
"bad". But, as observed in Table 2, if a cDNA has a com-
plex repeat in the last exon but all other composite fea-
tures are following the profile of a good cDNA, it will
classified as "questionable_cdna".
The lack of a polyA tail at the 3' end is also negatively con-
sidered during the quality assessment process, because a
polyA tail is a canonical motif that strongly promotes
translation initiation through secondary structures, such
as hairpins [34]. And moreover polyA+ RNAs have been
found in the interchromatin granule clusters (IGCs) in the
nucleus which are not transported to the cytoplasm, as
would be the case if they represented protein-coding
mRNAs, but do have regulatory functions [35].BMC Bioinformatics 2006, 7:473 http://www.biomedcentral.com/1471-2105/7/473
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Table 2: Decision rules for cDNA sequence quality evaluation in CAFTAN.
Type Coverage Mapping Exons Sscore (%) SS_type Contamination
_test
Signal Tail VEGA 
match
Uncovered False
Bad_se_cdna True Unmapped 1
Bad_me_cdna True Unmapped > 1
Bad_se_cdna True Partial 
mapped
1
Bad_me_cdna True Partial 
mapped
> 1 < 100
Questionable_me True Partial 
mapped
> 1 100 No 
contamination
Bad_me_cdna True Partial 
mapped
> 1 100 Any 
contamination
Good_se_cdna True Mapped 1 No 
contamination
++
Bad_se_cdna True Mapped 1 No 
contamination
--
Questionable_se True Mapped 1 Genomic polyA + + Perfect
Bad_se True Mapped 1 Genomic polyA + + No Perfect
Bad_se_polyA_primed True Mapped 1 Genomic polyA + -
Good_se True Mapped 1 No 
contamination
+ - Perfect
Questionable_se True Mapped 1 No 
contamination
+ - No Perfect
Bad_se True Mapped 1 Repeats - -
Bad_se_polyA_primed True Mapped 1 No 
contamination
-+
Good_se True Mapped 1 Repeats + - Perfect
Questionable_se True Mapped 1 Repeats + - No Perfect
Bad_se True Mapped 1 Genomic polyA - -
Bad_me True Mapped > 1 Ssc <= 60
Bad_me True Mapped > 1 60 < Ssc < = 100 Good SS* Mixed 
contamination
Bad_me True Mapped > 1 60 < Ssc < 80 Good SS* Genomic polyA
Bad_me True Mapped > 1 Ssc = > 90 Bad SS + Mixed
Bad_me True Mapped > 1 60 < Ssc < 90 Bad SS +
Good_me_cdna True Mapped > 1 60 < Ssc <= 100 Good SS* No 
contamination
Good_me_cdna True Mapped > 1 60 < Ssc <= 100 Good SS* No 
contamination
++
Good_me_cdna True Mapped > 1 60 < Ssc <= 100 Good SS* No 
contamination
+-
Good_me_cdna True Mapped > 1 Ssc > = 80 Good SS* No 
contamination
--
Good_me_cdna True Mapped > 1 Ssc > = 80 Good SS* No 
contamination
-+
Good_me_cdna True Mapped >1 Ssc > = 80 Good SS* Repeats
Good_me_cdna True Mapped > 1 Ssc > = 90 Bad SS + No 
contamination
Good_me_cdna True Mapped > 1 Ssc > = 90 Bad SS + Repeats
Questionable_me True Mapped > 1 60 < Ssc < 80 Good SS* No 
contamination
--
Questionable_me True Mapped > 1 60 < Ssc < 80 Good SS* No 
contamination
-+
Questionable_me True Mapped > 1 Ssc > = 80 Good SS* Genomic polyA
Questionable_me True Mapped > 1 60 < Ssc < 80 Good SS* Repeats
Questionable_me True Mapped > 1 Ssc > = 90 Bad SS + Genomic PolyA
The definition of splice site types (Ss type) is described in Table 1. * Good SS are Canonical Splice sites, non-canonical, and u12. Bad SS + are 
unknown and antisense combinations of donor and acceptors (Table 1)BMC Bioinformatics 2006, 7:473 http://www.biomedcentral.com/1471-2105/7/473
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CAFTAN uses the information recovered from VEGA and
ENSEMBL (Table 2). If there is a perfect match of a VEGA/
ENSEMBL transcript ("best_transcript score" > 0.98) to the
query cDNA, then the cDNA will be classified as "Good"
or "Questionable". If the match is not perfect
("best_transcript score" <= 0.98) the classification will
depend on the presence/absence/type of contamination
and/or the presence or absence of polyA signal and polyA
tail (for details look at Table 2). If there is at the same time
a mixed contamination (Genomic polyA and repeats con-
tamination) the cDNA will be considered always "Bad".
Although the presence of CpG islands is always checked,
their presence or absence is not taken into account in the
decision tree. It has been proven in mammalian genomes
that many genes are not necessarily associated with these
regions. Nevertheless, this feature could be useful in the
detection of 5' cDNA's completeness by further manual
verification. A major amount of protein-coding genes
transcription start sites (TSS) – around 70% – are found to
be near CpG islands [36].
Evaluation sets
We generated and analyzed two cDNA sets in order to
evaluate the performance of our method. The first set con-
tained 5,954 "known protein-coding" cDNAs extracted
from the human VEGA database, which is the current
"golden" annotation standard in mammalians. For com-
parison we created a set of 3,000 "bad" cDNAs sequences.
To do this, we selected from the human genome i) ran-
domly a chromosome, ii) the beginning of the cDNA
according to the length of the randomly selected chromo-
some, and iii) a random number of exons, introns and
their lengths. Limits for the introns and exons lengths
were taken from the work of Sakharkar et al., [37]. Ran-
domly generated exons were retrieved from the human
assembly NCBI36 and joined to generate cDNAs. For this
set of "bad" cDNAs a polyA tail was artificially added at
the 3'end of the terminal "exon".
Program specifications
CAFTAN was written using Object Oriented Perl, and has
been implemented as a downloadable stand-alone ver-
sion available at [38]. Preprocessing of cDNA sequences
with the program Polyasignal is mandatory for the stand-
alone version of CAFTAN, as this takes output files of Pol-
yasignal as input. CAFTAN requires a previous installation
of Bioperl-1.2 (or greater) and of ENSEMBL [22] because
it utilizes the ENSEMBL Perl API [39] and EMBOSS (up to
version 3.0).
CAFTAN is also available under the W3H task system at
the DKFZ [40]. This Web version takes as input multiple
Fast A sequences file and a BLAT [23] output from the
FastA sequence file in pSL format with header.
The Polyasignal source code is available through the
authors and it has been submitted to be included in future
releases of the EMBOSS package. Queries in the ENSEMBL
database can be done "remote" at the ENSEMBL site or
"locally" provided the user has installed the ENSEMBL
databases. The default is set to remote.
Results and Discussion
CAFTAN allows the analysis of several thousands of
cDNAs within a few minutes, giving the curator/scientist
an overview about the likelihood of having fully spliced/
processed cDNAs and providing the already existing
annotation for the cDNA set. It supports the rejection of
low quality cDNAs and helps selecting novel splice vari-
ants, and/or completely novel transcripts for new experi-
ments.
The evaluation described in the implementation section
to assess the performance of CAFTAN showed that it is
able to correctly classify more than 85% of 5950 selected
"known protein-coding" VEGA cDNAs as high quality
multi- or single-exon (Table 3). It identified as good 80,6
% of the single exon cDNAs and 85 % of the multiple
exon cDNAs. In the set of random generated cDNAs the
fraction of cDNAs that was predicted, as high quality was
only 5 %, almost all being single exon cDNAs. VEGA is a
central repository for manual annotation of vertebrate fin-
ished genome sequences thus the "known protein coding"
cDNA set was selected as a reference for the evaluation.
When we analyzed the VEGA cDNAs classified by CAF-
TAN as "Bad_se" (37/191) and "Bad_multiple_exons"
(791/5759) we found, that in the case of the group classi-
fied as "bad_multiple_exon_cdna", all of them lacked the
presence of a polyA signal but had a perfect match to
VEGA transcripts. The manual inspection by an expert
curator of these VEGA CDNAs sequences showed that
most of the VEGA cDNAs sequences were not complete,
part of the 3'UTR region failing or having an artefact
3'UTR end. In Table 4, there is a summary of 15 selected
cases, in which only 2 of these cases (No. 4 and No. 8) are
false negatives, (e.g. case No. 8 has a non common polyA
signal which is not contemplated in the Polyasignal pro-
gram). On the other hand, when inspecting the VEGA
cDNAs group classified as bad single exon ("Bad_se" 37/
191) we found that most of them lacked a polyA signal or
had a non-conventional one. When checked in detail
(Table 5), 19 of these 37 "bad_single_exons" were found
to be Histone coding cDNAs. Histone coding cDNAs do
not undergo polyadenylation due to the fact that they
have a very short life and do not need to be stabilized. The
rest either did not have a complete 3'UTR or they were
even products of internal priming events [41,42] compli-
cating a proper distinction between these cases. While the
lack of a polyA signal does not necessarily indicate an arti-BMC Bioinformatics 2006, 7:473 http://www.biomedcentral.com/1471-2105/7/473
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fact, internal priming certainly is, and such cDNAs must
be regarded as noise for our porpouse. Taking these results
into account, the CAFTAN can correctly classify up to 90
% of the cases, thus proving to be highly efficient. The
number of "right" and "wrong" classified single exon
cDNAs in the VEGA set was very similar to the respective
values in the random set.
It is worth mentioning that the "Splice Sites Score" is the
composite features that provided the most reliable infor-
mation about the quality of multi-exon cDNAs.
When analyzing the remaining "bad" multiple exons
(false negatives) cDNAs, we saw that most of the wrong
classification was due to mistakes in the mapping process.
BLAT is the current fastest algorithm to map sequences to
a genome. It is designed to find sequences of 95% and
greater similarity in a minimum of 33 bases, thus it may
miss shorter sequence alignments, making the mapping
of shorter exons especially problematic. An alternative
would be the use of MEGABLAST [43], and the subse-
quent use of SIM4 [44]. We have already used such an
approach for all mammalian genomes in cDNA2Genome
[45] and recently the same approach was used for Arabi-
dopsis thaliana by Hayden et, al[46]. This approach implies
a much larger processing time and a big bias through the
selection of exons containing canonical splice sites by
Sim4 [47]. Other programs like EST_Genome [48] or like
Spidey [49] are also accompanied by strong preferences in
it's scoring for GT...AG splicing sites [50]. This bias is
reduced when using BLAT because it provides pair-wise
alignment information but not explicit predictions of
splice junctions.
Several cDNAs were wrongly classified because of mis-
alignments in the first and last exons that were due to the
presence of repeat elements in the UTR regions, and to
misalignments of 3' terminal poly-A sequences. All these
cDNAs were classified as being of questionable quality.
Any cDNAs in this category should not be discarded but a
rating in this category should rather be an indicator to the
scientist curator that he or she should look in detail in the
CAFTAN output and to take an expert decision on the
quality of the query cDNA. The cDNAs in this category
were about 5% in the multi-exon class of cDNAs.
The transcript score, which evaluates the total overlap
between a query cDNA and the VEGA/ENSEMBL anno-
tated transcripts, was for both cDNAs types -when using
the human NCBI assembly 35- between 1 and 0.8 in 99.5
% of the cases, where 1 is a perfect match. The results pre-
sented here, are based on assembly 36 and so when look-
ing in the VEGA annotation, the average of the transcript
score is lower. This is due to the fact that VEGA still uses
the assembly NCBI35, while ENSEMBL and all the data-
bases available for BLAT use the assembly NCBI36. This is
a temporal problem that affects only to those chromo-
somes, which changed the mapping coordinates in the
NCBI36 and will be solved in the moment that VEGA
changes to the assembly NCBI36. In the random gener-
ated cDNAs sets all transcript scores remained under 0.23
%.
CAFTAN was implemented as a fast approach towards the
selection of cDNAs from resources that have been gener-
ated in high-throughput projects. A more accurate algo-
rithm like MegaBlast would certainly improve the
alignments, but this would be at the cost of speed. In view
of the high success rate of CAFTAN in the analysis of the
VEGA and random cDNA sets already obtained with
BLAT, we decided not to compromise speed for a possible
small improvement in reliability. Nevertheless, future
implementations of CAFTAN will be allowing users to
upload either BLAT or MegaBlast outputs or they can
already use cDNA2Genome, which annotates cDNAs
using this approach but which needs long running times.
Both the WEB and the downloadable versions are modu-
lar and will further permit the implementation of addi-
tional filtering tools for alternative mapping methods.
Additionally to the cDNA quality classification, CAFTAN
provides extensive information about each cDNA, which
Table 3: CAFTAN results for the annotated VEGA cDNAs and for the 3000 randomly generated cDNAs.
CDNA Known VEGA Transcripts Random Sequences
Number Percent Number Percent
Good single exon cDNA 154 2.58 % 46 1.53 %
Good multiple exon cDNA 4911 82.53 % 1 0.03 %
Questionable single exon cDNA 0 0.00 % 0 0 %
Questionable multiple exon cDNA 57 0.96 % 0 0 %
Bad single exon cDNA 37 0.62 % 115 3.83 %
Bad multiple exon cDNA 791 13.29 % 2666 88.86 %
Not mapped 0 0.00 % 172 5.73 %
Total 5950 3000BMC Bioinformatics 2006, 7:473 http://www.biomedcentral.com/1471-2105/7/473
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is divided in different tab tabulated outputs tables (Figure
1). The "Mapping" output contains the exact mapping
information of the cDNAs to the selected genome after fil-
tering of the BLAT exons. The "Evaluation" output classi-
fies the cDNAs according to their quality and the presence
or lack of the features described above. It provides the fol-
lowing fields: contamination, number of mismatches in
the 5' and 3'end, mapping classification, exon number,
splice site number, score and type, polyA signal number
type and score, repeats, repeats in the 3' end. "VEGA anno-
tation" and "ENSEMBL annotation" outputs contain
detailed annotation of genes and transcripts in VEGA/
ENSEMBL overlapping the analyzed cDNAs. This file
includes a quality score for each overlapping gene and
transcript that is based on the number of shared positions
over the total length of the overlapping annotated gene/
transcript. The table also contains gene identifiers, begin
and end of mapping positions, chromosome number,
number of exons, and information on shared and missed
exons. "VEGA detailed annotation" and "ENSEMBL detailed
annotation" outputs provide further details at the individ-
ual exon level, plus positional differences between anno-
tated VEGA/ENSEMBL exons and exons of the query
cDNA. The "Polyasignal" output contains the results of the
search for polyA signals and polyA tails in the cDNAs
using the selected regular expressions. The final output of
CAFTAN is an "XML" file that contains all information
from all outputs obtained in the process. This XML file can
be directly integrated in user databases and used for fur-
ther analysis with other programs.
Currently we are working on the development of super-
vised learning algorithms for the improvement of cDNA
quality prediction, especially for single exon cDNAs. In
the future CAFTAN will be additionally extended towards
the classification of transcripts that are products of exon
skipping events, alternative usage of Poly (A) sites, and the
presence of alternative promoters and transcription start
sites (TSS).
The results described here were obtained with the default
parameters established for CAFTAN and optimized for
mammals. One of the advantages of CAFTAN is that it
allows the adjustment of parameters to adapt it to any
Table 4: Selection of cDNAs classified as "bad_multiple_exon_cdna" by CAFTAN.
cDNA_Name Signal VEGA_matcht VEGA match Problem
1 OTTHUMT00000002088 No signal perfect TNFRSF14-001 The sequence ends with the poly A signal AAUAUA
2 OTTHUMT00000002210 No signal perfect SLC35E2-001 Partial Sequence in the 3' UTR end. The sequence is longer 
and for that reason is not possible to find the polyA signal
3 OTTHUMT00000003581 No signal perfect PARK7-005 Partial Sequence in the 3' UTR end. The sequence is longer 
and for that reason is not possible to find the polyA
4 OTTHUMT00000003582 No signal perfect PARK7-006 RPL20 Gen, eventually (A)ATGAA(A) signal
5 OTTHUMT00000004064 No signal perfect C1orf86-001 Not a perfect cDNA, the last exon fails and for that reason 
it is not possible to find a polyA signal
6 OTTHUMT00000004201 No signal perfect PHF13-001 False 3' end (artefact), the real 3' end is upstream from this 
point and is supported by many ESTs and a canonical 
polyA signal
7 OTTHUMT00000005013 No signal perfect CTNNBIP1-002 Good cDNA, this cDNA does not have canonical or 
typical non-canocial polyA signals checked in CAFTAN. 
Putative polyA signal: ATGTAAATAT
8 OTTHUMT00000005014 No signal perfect CTNNBIP1-003 The real 3' UTR is a little bit longer and contains a 
canonical polyA signal 20 bp upstream from the polyA tail.
9 OTTHUMT00000005015 No signal perfect CTNNBIP1-004 Partial Sequence in the 3' UTR end, fail the terminal bases, 
which make a perfect canonical polyA signal (AAUAAA) 
15 bp upstream from the polyA tail
10 OTTHUMT00000005017 No signal perfect UBE4B-002 Partial Sequence in the 3' UTR end, fail many terminal 
bases, which make a perfect canonical polyA signal 
(AAUAAA)
11 OTTHUMT00000005070 No signal perfect SDF4-002 Partial Sequence in the 3' UTR end, fail almost all the 3 
'UTR
12 OTTHUMT00000005103 No signal perfect KIF1B-002 Partial Sequence in the 3' UTR end, fail almost all the 3 
'UTR
13 OTTHUMT00000005105 No signal perfect KIF1B-004 Partial Sequence in the 3' UTR end, fail almost all the 3 
'UTR
14 OTTHUMT00000005430 No signal perfect UBE2J2-001 Partial Sequence in the 3' UTR end, fail almost all the 3 
'UTR
All of them lack the presence of a polyA signal but have a perfect match to VEGA transcripts, as it should be expected. The manual inspection by an 
expert curator of these VEGA CDNAs showed that all of them but 2 (No. 4 and No. 8) where not complete failing part of the 3'UTR region or 
having artifact 3' end like No. 6.BMC Bioinformatics 2006, 7:473 http://www.biomedcentral.com/1471-2105/7/473
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Table 5: Selection of cDNAs classified as "bad_single_exon_cdna" by CAFTAN.
VEGA Transcript ID Description Transcript 
name
Problem
1 OTTHUMT00000033440 histone 2, H2ab HIST2H2AB-001 Histone mRNAs are not polyadenylated.
2 OTTHUMT00000040062 Small proline-rich protein 1A SPRR1A-001 Fails tail of the 3' end of the cDNA
3 OTTHUMT00000040078 histone 1, H3c HIST1H3C-001 Histone mRNAs are not polyadenylated.
4 OTTHUMT00000040083 histone 1, H2bb HIST1H2BB-001 Histone mRNAs are not polyadenylated.
5 OTTHUMT00000040098 histone 1, H3f HIST1H3F-001 Histone mRNAs are not polyadenylated.
6 OTTHUMT00000040100 histone 1, H2ad HIST1H2AD-001 Histone mRNAs are not polyadenylated.
7 OTTHUMT00000040108 histone 1, H2bf HIST1H2BF-001 Histone mRNAs are not polyadenylated.
8 OTTHUMT00000040109 histone 1, H2bg HIST1H2BG-001 Histone mRNAs are not polyadenylated.
9 OTTHUMT00000040110 histone 1, H2bh HIST1H2BH-001 Histone mRNAs are not polyadenylated.
10 OTTHUMT00000040111 histone 1, H2bi HIST1H2BI-001 Histone mRNAs are not polyadenylated.
11 OTTHUMT00000040119 histone 1, H4h HIST1H4H-001 Histone mRNAs are not polyadenylated.
12 OTTHUMT00000040138 histone 1, H2 HIST1H2BJ-001 Histone mRNAs are not polyadenylated.
13 OTTHUMT00000040154 histone 1, H2aj HIST1H2AJ-001 Histone mRNAs are not polyadenylated.
14 OTTHUMT00000040160 histone 1, H2al HIST1H2AL-001 Histone mRNAs are not polyadenylated.
15 OTTHUMT00000040162 histone 1, H2am HIST1H2AM-001 Histone mRNAs are not polyadenylated.
16 OTTHUMT00000042255 RP11-295F4.3-001 Fails tail of the 3' end of the cDNA
17 OTTHUMT00000042262 TAAR8-001 Signal 70 pb upstream. EST evidence from a shorter gene
18 OTTHUMT00000043372 histone 1, H1c HIST1H1C-001 Histone mRNAs are not polyadenylated.
19 OTTHUMT00000043452 histone 1, H3i HIST1H3I-001 Histone mRNAs are not polyadenylated.
20 OTTHUMT00000043453 histone 1, H3j HIST1H3J-001 Histone mRNAs are not polyadenylated.
21 OTTHUMT00000043884 histone H1 HIST1H1A-002 Histone mRNAs are not polyadenylated.
22 OTTHUMT00000044894 cysteinyl leukotriene 
receptor 2
CYSLTR2-001 Partial 3'UTR Sequence
23 OTTHUMT00000050610 G protein-coupled 
receptor 10
GPR10-001 Partial 3'UTR Sequence
24 OTTHUMT00000051889 Interferon, alpha 4 IFNA4-001 Internal primed
25 OTTHUMT00000051905 Interferon, alpha 6 IFNA6-001 Internal primed
26 OTTHUMT00000053504 T-cell acute lymphocytic 
leukemia 2
TAL2 Internal primed
27 OTTHUMT00000057327 G protein-coupled 
receptor 174
GPR174 Partial 3'UTR Sequence
28 OTTHUMT00000057879 Insulin receptor substrate 4 IRS4 Ends in the signal,
29 OTTHUMT00000059081 Potassium voltage-gated 
channel
KCNA10-001 Partial 3'UTR Sequence
30 OTTHUMT00000059124 Taste receptor, type 2, 
member 4
TAS2R4 Partial 3'UTR Sequence
31 OTTHUMT00000072293 A disintegrin ADAM21-001 Artifact, much longer than the real gene
32 OTTHUMT00000076126 MAS1 oncogene-like MAS1L-001 Partial 3'UTR Sequence
33 OTTHUMT00000087128 histone 2, H2ac HIST2H2AC-001 Histone mRNAs are not polyadenylated.
34 OTTHUMT00000147346 HsG1428-001 Partial 3'UTR Sequence
35 OTTHUMT00000147982 HsG647-001 Partial 3'UTR Sequence
36 OTTHUMT00000147994 HsG684-001 Presence of a repeat in the 3' UTR
37 OTTHUMT000001480 95 HsG2001-001 Partial 3'UTR Sequence
All of them lack the presence of a polyA signal but have a perfect match to VEGA transcripts, as it should be expected. The manual inspection by an 
expert curator of these VEGA CDNAs showed that 19 all of them are Histone coding cDNAs which do not go under polyadenylation. The rest 
either did not have a complete 3'UTR region or was an artifact 3'.BMC Bioinformatics 2006, 7:473 http://www.biomedcentral.com/1471-2105/7/473
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organism. The parameters can easily be changed in the
configuration file (Config.pm). The polyAsignal program
can be configured for other genome preferences, and the
rules to be taken into account can be modified for differ-
ent genomes. New organism's genomic databases can be
used as soon as they become available by adding them to
the configuration file. We think that it is a very useful pro-
gram for the annotation and research of unfinished
genomes. The use of CAFTAN as a first filtering step
should be followed by an ORF analysis like described by
Takeda et al. [51]. We further plan to extend the algorithm
to the analysis of ESTs as well.
Conclusion
We have developed a new high-throughput sequence
analysis tool, CAFTAN [see Additional file 1], which per-
forms a fast and reliable quality prediction of cDNAs. Sev-
eral thousand cDNAs can be analyzed in a short time,
giving the curator/scientist a first quick overview about
the quality and the already existing annotation of a set of
cDNAs. CAFTAN does not substitute the manual expert
curation and further detailed ORF analysis; however it
supports the rejection of low quality cDNAs and the selec-
tion of likely novel splice variants, and/or completely
novel transcripts. The successful exploitation of the large
number of available cDNA sequences and the respective
clones in functional genomics experiments necessitates
the fast distinction between noise and those cDNAs that
are valid for further detailed and manual annotation.
Limitations
- Existing databases in ENSEMBL
- The need of a BLAT mapping output.
- The performance of CAFTAN depends on the number of
input cDNAs and on the overall machine load. Analysis of
the 4,000 cDNAs from the VEGA set took 21.89 seconds
on a six processor SUN Enterprise. The remote use of the
MSQL ENSEMBL database could be slowed down when
the ENSEMBL server is extensively accessed, favoring a
local implementation.
Availability
Operating system(s): Linux, Unix
Programming language: Perl5
Requirements:
- For the download distribution it is necessary to install
ENSEMBL package, bioperl-2.1 or higher, and the Perl
DBI Package prior to the installation of CAFTAN.
- Use of the web version requires a HUSAR account at [52].
License:
Restrictions to use by non-academics: license needed
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